WallStreetZenWallStreetZen

NASDAQ: KURA
Kura Oncology Inc Stock Ownership - Who owns Kura Oncology?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Kura Oncology Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Stephen DaleChief Medical Officer2024-01-304,825$21.55
$103.98kSell
Stephen DaleChief Medical Officer2024-01-292,758$17.80
$49.09kSell
Stephen DaleChief Medical Officer2024-01-294,400$17.80
$78.32kSell
Thomas James DoyleSVP Finance Accounting2024-01-29963$17.80
$17.14kSell
Thomas James DoyleSVP Finance Accounting2024-01-29761$17.80
$13.55kSell
Thomas James DoyleSVP Finance Accounting2024-01-29594$17.80
$10.57kSell
Kathleen FordChief Operating Officer2024-01-291,496$17.80
$26.63kSell
Teresa Brophy BairChief Legal Officer2024-01-292,053$17.80
$36.54kSell
Troy Edward WilsonPresident and CEO2024-01-2484,107$20.23
$1.70MSell
Troy Edward WilsonPresident and CEO2024-01-2484,107$6.15
$517.26kBuy

1 of 2

KURA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KURA insiders and whales buy or sell their stock.

KURA Shareholders

What type of owners hold Kura Oncology Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Inc9.68%7,373,228$144.88MInstitution
Blackrock Inc9.61%7,315,647$143.75MInstitution
Suvretta Capital Management LLC9.12%6,946,230$136.49MInstitution
Ecor1 Capital LLC7.63%5,806,871$114.11MInstitution
Deerfield Management Company LP Series C6.98%5,312,733$104.40MInstitution
Ecor1 Capital Fund Qualified LP5.79%4,408,097$86.62MInsider
Vanguard Group Inc5.30%4,037,691$79.34MInstitution
Avoro Capital Advisors LLC3.91%2,980,000$58.56MInstitution
State Street Corp3.84%2,921,810$57.41MInstitution
Holocene Advisors LP3.20%2,437,463$47.90MInstitution

1 of 3

KURA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KURA90.77%9.23%Net BuyingNet Selling
ADMA74.12%24.57%Net SellingNet Selling
ARDX38.01%61.99%Net SellingNet Selling
EWTX84.23%15.77%Net BuyingNet Buying
PTGX79.94%20.06%Net SellingNet Selling
View Top Biotech Stocks

Kura Oncology Stock Ownership FAQ

Who owns Kura Oncology?

Kura Oncology (NASDAQ: KURA) is owned by 103.42% institutional shareholders, 10.51% Kura Oncology insiders, and 0.00% retail investors. Ecor1 Capital Fund Qualified LP is the largest individual Kura Oncology shareholder, owning 4.41M shares representing 5.79% of the company. Ecor1 Capital Fund Qualified LP's Kura Oncology shares are currently valued at $86.62M.

If you're new to stock investing, here's how to buy Kura Oncology stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.